Notes on interpretation
The present report is based on 2007 'finalised' data from each state or territory agreed upon in September 2008 and represents a snap shot of the year after duplicate records and incorrect or incomplete data were removed. Therefore, totals in this report may vary slightly from the totals reported in CDI quarterly publications.
Analyses in this report were based on the date of disease diagnosis in an attempt to estimate disease activity within the reporting period. The date of diagnosis is the onset date or where the date of onset was not known, the earliest of the specimen collection date, the notification date, or the notification receive date. As considerable time may have elapsed between the onset and diagnosis dates for hepatitis B (unspecified), hepatitis C (unspecified) and tuberculosis, the earliest of specimen date, health professional notification date or public health unit notification receive date was used for these conditions.
Notified cases can only represent a proportion (the 'notified fraction') of the total incidence (Figure 1) and this has to be taken into account when interpreting NNDSS data. Moreover, the notified fraction varies by disease, by jurisdiction and by time.
Figure 1. Communicable diseases notifiable fraction
A survey of jurisdictional public health departments was conducted in 2005 to ascertain the source of each notification.11 Notifications from Queensland were almost entirely supplied by laboratories (Table 2). In 3 other jurisdictions more than 90% of notifications originated from the laboratory. In 3 states almost half of the notifications were reported by both the doctor and laboratory. Only New South Wales, South Australia and Western Australia reported that greater than 15% of notifications in their jurisdictions originated from doctors only.
Table 2: Percentage of notifications from different sources, Australia, 2005, by state or territory
State or territory |
Source of notifications | ||
---|---|---|---|
Laboratory only | Doctor only | Laboratory and doctor | |
ACT | 98 |
1 |
1 |
NSW | 70–80 |
20–30 |
<1 |
NT | 95 |
5 |
<1 |
Qld | 99 |
1 |
<1 |
SA | 24 |
17 |
59 |
Tas | 95 |
5 |
<1 |
Vic | 50 |
7 |
43 |
WA | 27 |
15 |
58 |
Source: Oxenford, Chapter 3 Current practices surrounding reporting of notifiable diseases by laboratories to state and territory health departments.11
Methods of surveillance vary between states and territories, each having different requirements for notification by medical practitioners, laboratories and hospitals. Although the National Notifiable Diseases List2 was established, some diseases are not yet notifiable in all 8 jurisdictions (Table 3).
Table 3: Diseases notified to the National Notifiable Diseases Surveillance System, Australia, 2007
Disease |
Data received from |
---|---|
Bloodborne diseases |
|
Hepatitis (NEC) | All jurisdictions |
Hepatitis B (incident) | All jurisdictions |
Hepatitis B (unspecified)* | All jurisdictions |
Hepatitis C (incident) | All jurisdictions except Queensland |
Hepatitis C (unspecified)*,† | All jurisdictions |
Hepatitis D | All jurisdictions |
Gastrointestinal diseases |
|
Botulism | All jurisdictions |
Campylobacteriosis‡ | All jurisdictions except New South Wales |
Cryptosporidiosis | All jurisdictions |
Haemolytic uraemic syndrome | All jurisdictions |
Hepatitis A | All jurisdictions |
Hepatitis E | All jurisdictions |
Listeriosis | All jurisdictions |
Salmonellosis | All jurisdictions |
Shigellosis | All jurisdictions |
STEC,VTEC§ | All jurisdictions |
Typhoid | All jurisdictions |
Quarantinable diseases |
|
Cholera | All jurisdictions |
Highly pathogenic avian influenza in humans | All jurisdictions |
Plague | All jurisdictions |
Rabies | All jurisdictions |
Severe acute respiratory syndrome | All jurisdictions |
Smallpox | All jurisdictions |
Viral haemorrhagic fever | All jurisdictions |
Yellow fever | All jurisdictions |
Sexually transmissible infections |
|
Chlamydial infections|| | All jurisdictions |
Donovanosis | All jurisdictions |
Gonococcal infection | All jurisdictions |
Syphilis – < 2 years duration* | All jurisdictions |
Syphilis – > 2 years or unspecified duration* | All jurisdictions except South Australia |
Syphilis – congenital | All jurisdictions |
Vaccine preventable diseases |
|
Diphtheria | All jurisdictions |
Haemophilus influenzae type b | All jurisdictions |
Influenza (laboratory confirmed)¶ | All jurisdictions |
Measles | All jurisdictions |
Mumps | All jurisdictions |
Pertussis | All jurisdictions |
Pneumococcal disease (invasive) | All jurisdictions |
Poliomyelitis | All jurisdictions |
Rubella | All jurisdictions |
Rubella – congenital | All jurisdictions |
Tetanus | All jurisdictions |
Varicella zoster (chickenpox)** | All jurisdictions except New South Wales and Victoria |
Varicella zoster (shingles)** | All jurisdictions except New South Wales and Victoria |
Varicella zoster (unspecified)** | All jurisdictions except New South Wales and Victoria |
Vectorborne diseases |
|
Barmah Forest virus infection | All jurisdictions |
Dengue virus infection | All jurisdictions |
Flavivirus infection (NEC)†† | All jurisdictions |
Japanese encephalitis virus infection | All jurisdictions |
Kunjin virus infection‡‡ | All jurisdictions |
Malaria | All jurisdictions |
Murray Valley encephalitis virus infection | All jurisdictions |
Ross River virus infection | All jurisdictions |
Zoonoses |
|
Anthrax | All jurisdictions |
Australian bat lyssavirus | All jurisdictions |
Brucellosis | All jurisdictions |
Leptospirosis | All jurisdictions |
Lyssavirus (NEC) | All jurisdictions |
Ornithosis | All jurisdictions |
Q fever | All jurisdictions |
Tularaemia | All jurisdictions |
Other bacterial infections |
|
Legionellosis | All jurisdictions |
Leprosy | All jurisdictions |
Meningococcal infection§§ | All jurisdictions |
Tuberculosis | All jurisdictions |
* Unspecified hepatitis and syphilis includes cases in whom the duration of infection could not be determined.
† In Queensland, includes incident hepatitis C cases.
‡ Notified as 'foodborne disease' or 'gastroenteritis in an institution' in New South Wales.
§ Infection with Shiga toxin/verotoxin-producing Escherichia coli (STEC/VTEC).
|| Includes Chlamydia trachomatis identified from cervical, rectal, urine, urethral, throat and eye samples, except for South Australia, which reports only genital tract specimens; Northern Territory, which excludes ocular specimens; and Western Australia, which excludes ocular and perinatal infections.
¶ Laboratory confirmed influenza was not a notifiable disease in South Australia but reports were forwarded to the National Notifiable Diseases Surveillance System.
** Nationally notifiable from 2006 and first full year of national reporting from 2007.
†† Flavivirus (NEC) replaced Arbovirus (NEC) from 1 January 2004.
‡‡ In the Australian Capital Territory, Murray Valley encephalitis virus infection and Kunjin virus infection are combined under Murray Valley encephalitis virus infection.
§§ Only invasive meningococcal disease is nationally notifiable. However, New South Wales and South Australia also report conjunctival cases.
NEC Not elsewhere classified.
Changes in surveillance practices may have been introduced in some jurisdictions and not in others, and makes the comparison of data across jurisdictions difficult. In this report, some information was obtained from states and territories, including changes in surveillance practices, screening practices, laboratory practices, and major disease control or prevention initiatives to assist in the interpretation of the 2007 data.
Postcode information usually reflects the residential location of the case, but this does not necessarily represent the place where the disease was acquired. In December 2008, the CDNA endorsed the NNDSS cross-border notification protocol, which determines that the jurisdiction of residence of a case has the responsibility of reporting the notification to NNDSS. This was implemented from 1 January 2009, and may also affect some retrospective notifications, including those reported in 2007, by removing duplicates and preventing the loss of notification data in NNDSS.
Data completeness was assessed for the notification's sex, age at onset, and indigenous status, and reported as the proportion of complete notifications. The completeness of data in this report is summarised in the Results.
The per cent data completeness was defined as:
Per cent data completeness = (total notifications – missing or unknown) / total notifications x 100
The indigenous status was defined by the following nationally accepted values:12
1=Indigenous – (Aboriginal but not Torres Strait Islander origin)
2=Indigenous – (Torres Strait Islander but not Aboriginal origin)
3=Indigenous – (Aboriginal and Torres Strait Islander origin)
4=Not indigenous – ( not Aboriginal or Torres Strait Islander origin)
9=Not stated, blank, unknown
Notes on cases definitions
Each notifiable disease is governed by a national surveillance case definition for reporting to NNDSS. These case definitions were agreed by CDNA and implemented nationally from January 2004 and were used by all jurisdictions for the first time in 2005. The national surveillance case definitions and their status are available from http://www.health.gov.au/casedefinitions
CDI Search
Communicable Diseases Intelligence subscriptions
Sign-up to email updates: Subscribe Now
Communicable Diseases Surveillance
This issue - Vol 33 No 2, June 2009
NNDSS Annual report 2007
Communicable Diseases Intelligence